Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2013-04-24 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BLAIN (44130), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L ISAC : revenue, balance sheet and financial ratios
PHARMACIE DE L ISAC is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BLAIN (44130),
this company of category PME
shows in 2025 a net income positive of 338 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L ISAC (SIREN 792757601)
Indicator
2025
2024
2023
2022
2021
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
337 767 €
328 325 €
344 584 €
459 020 €
291 768 €
258 802 €
211 983 €
237 571 €
236 675 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE L ISAC generates positive net income of 338 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 237 k€ -> 338 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
337 767 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 94%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
93.767%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.911%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
2025
Debt ratio
257.845
163.162
109.159
84.363
390.872
207.556
181.469
127.579
93.767
Financial autonomy
25.33
34.665
42.905
48.96
17.815
27.78
30.249
36.979
43.911
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
93.772025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-11 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE L ISAC (93.77) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
43.91%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE L ISAC (43.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 233.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
233.513
Liquidity indicators evolution PHARMACIE DE L ISAC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
2025
Liquidity ratio
250.713
216.487
169.97
236.313
187.559
217.509
189.664
202.683
233.513
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
233.512025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+17 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE L ISAC (233.51) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE L ISAC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE L ISAC is estimated at
5 365 468 €
(range 3 641 032€ - 8 419 159€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3641k€5365k€8419k€
5 365 468 €Range: 3 641 032€ - 8 419 159€
NAF 5 année 2025
Valuation method used
Net Income Multiple
337 767 €
×
15.9x
=5 365 469 €
Range: 3 641 033€ - 8 419 160€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L ISAC with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L ISAC
What is the revenue of PHARMACIE DE L ISAC ?
The revenue of PHARMACIE DE L ISAC is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L ISAC profitable?
Yes, PHARMACIE DE L ISAC generated a net profit of 338 k€ in 2025.
Where is the headquarters of PHARMACIE DE L ISAC ?
The headquarters of PHARMACIE DE L ISAC is located in BLAIN (44130), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE DE L ISAC ?
The tax return of PHARMACIE DE L ISAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L ISAC operate?
PHARMACIE DE L ISAC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart